Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trial

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

Cornelius Knabbe, Marc E. Lippman, Lalage M. Wakefield et al. · Cell · 1987 · 982 citations

Life Sciences, Cell Biology, Oncology +12

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

Tommy� Fornander, Björn Cedermark, Anders Mattsson et al. · The Lancet · 1989 · 930 citations

Medicine, Oncology, Pharmacology +12

Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment.

Ernst A. Lien, Einar Solheim, Oscar A. Lea et al. · PubMed · 1989 · 234 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

Françoise Vignon, M.M. Bouton, Henri Rochefort · Biochemical and Biophysical Research Communications · 1987 · 205 citations

Medicine, Cancer Biology, Oncology +10